COVID-19 vaccination status and the risk of developing lung diseases: A Mendelian randomization study.

Publication date: Jul 11, 2025

Recent studies have suggested an increased incidence of various lung diseases following COVID-19 vaccination. However, causal relationships have not been definitively established. We conducted a two-sample Mendelian randomization (MR) study using publicly available genome-wide association study data to investigate potential causal relationships between COVID-19 vaccination status as the exposure and 14 different lung diseases as outcomes. The analytical methods included random-effects inverse-variance weighting, MR Egger, and weighted median, with additional heterogeneity and sensitivity analyses. Seven instrumental variables for exposure were selected (P 

Concepts Keywords
Genome causal association
Increased COVID-19
Mendelian COVID-19 vaccination
Randomization COVID-19 Vaccines
Vaccines COVID-19 Vaccines
Genome-Wide Association Study
Humans
Lung Diseases
Mendelian randomization
Mendelian Randomization Analysis
public health
respiratory diseases
Risk Factors
SARS-CoV-2
Vaccination

Semantics

Type Source Name
disease MESH COVID-19
disease MESH lung diseases
disease MESH respiratory diseases

Original Article

(Visited 11 times, 1 visits today)